AbbVie launches Produodopa for treatment of parkinson's disease in EU
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
Express Scripts to add Zepbound to National Preferred Formulary
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
Subscribe To Our Newsletter & Stay Updated